514 related articles for article (PubMed ID: 33467029)
1. Natural and Nature-Derived Products Targeting Human Coronaviruses.
Vougogiannopoulou K; Corona A; Tramontano E; Alexis MN; Skaltsounis AL
Molecules; 2021 Jan; 26(2):. PubMed ID: 33467029
[TBL] [Abstract][Full Text] [Related]
2. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
[TBL] [Abstract][Full Text] [Related]
3. Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.
Idrees M; Khan S; Memon NH; Zhang Z
Curr Pharm Biotechnol; 2021; 22(4):444-450. PubMed ID: 32619167
[TBL] [Abstract][Full Text] [Related]
4. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
Khare P; Sahu U; Pandey SC; Samant M
Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
[TBL] [Abstract][Full Text] [Related]
5. Valinomycin as a potential antiviral agent against coronaviruses: A review.
Zhang D; Ma Z; Chen H; Lu Y; Chen X
Biomed J; 2020 Oct; 43(5):414-423. PubMed ID: 33012699
[TBL] [Abstract][Full Text] [Related]
6. The Potential of Algal Biotechnology to Produce Antiviral Compounds and Biopharmaceuticals.
Rosales-Mendoza S; García-Silva I; González-Ortega O; Sandoval-Vargas JM; Malla A; Vimolmangkang S
Molecules; 2020 Sep; 25(18):. PubMed ID: 32899754
[TBL] [Abstract][Full Text] [Related]
7. Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus.
Leneva I; Kartashova N; Poromov A; Gracheva A; Korchevaya E; Glubokova E; Borisova O; Shtro A; Loginova S; Shchukina V; Khamitov R; Faizuloev E
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452529
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Antiviral Coatings for High-Touch Surfaces by Using Human Coronaviruses HCoV-229E and SARS-CoV-2.
Butot S; Baert L; Zuber S
Appl Environ Microbiol; 2021 Sep; 87(19):e0109821. PubMed ID: 34288707
[TBL] [Abstract][Full Text] [Related]
9. Broad-spectrum coronavirus antiviral drug discovery.
Totura AL; Bavari S
Expert Opin Drug Discov; 2019 Apr; 14(4):397-412. PubMed ID: 30849247
[TBL] [Abstract][Full Text] [Related]
10. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.
de Wilde AH; Jochmans D; Posthuma CC; Zevenhoven-Dobbe JC; van Nieuwkoop S; Bestebroer TM; van den Hoogen BG; Neyts J; Snijder EJ
Antimicrob Agents Chemother; 2014 Aug; 58(8):4875-84. PubMed ID: 24841269
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L
Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702
[TBL] [Abstract][Full Text] [Related]
12. Role of heterocyclic compounds in SARS and SARS CoV-2 pandemic.
Negi M; Chawla PA; Faruk A; Chawla V
Bioorg Chem; 2020 Nov; 104():104315. PubMed ID: 33007742
[TBL] [Abstract][Full Text] [Related]
13. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
Báez-Santos YM; St John SE; Mesecar AD
Antiviral Res; 2015 Mar; 115():21-38. PubMed ID: 25554382
[TBL] [Abstract][Full Text] [Related]
14. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
[TBL] [Abstract][Full Text] [Related]
15. A Novel Frameshifting Inhibitor Having Antiviral Activity against Zoonotic Coronaviruses.
Ahn DG; Yoon GY; Lee S; Ku KB; Kim C; Kim KD; Kwon YC; Kim GW; Kim BT; Kim SJ
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452503
[TBL] [Abstract][Full Text] [Related]
16. SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review.
Nascimento Junior JAC; Santos AM; Quintans-Júnior LJ; Walker CIB; Borges LP; Serafini MR
Expert Opin Ther Pat; 2020 Aug; 30(8):567-579. PubMed ID: 32429703
[TBL] [Abstract][Full Text] [Related]
17. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
[TBL] [Abstract][Full Text] [Related]
18. Antiviral drugs specific for coronaviruses in preclinical development.
Adedeji AO; Sarafianos SG
Curr Opin Virol; 2014 Oct; 8():45-53. PubMed ID: 24997250
[TBL] [Abstract][Full Text] [Related]
19. Natural product-derived phytochemicals as potential agents against coronaviruses: A review.
Mani JS; Johnson JB; Steel JC; Broszczak DA; Neilsen PM; Walsh KB; Naiker M
Virus Res; 2020 Jul; 284():197989. PubMed ID: 32360300
[TBL] [Abstract][Full Text] [Related]
20. Antiviral strategies against human coronaviruses.
Pyrc K; Berkhout B; van der Hoek L
Infect Disord Drug Targets; 2007 Mar; 7(1):59-66. PubMed ID: 17346212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
